Ava C Kelley

Nearly Half of TP53 Germline Variants Predicted To Be Pathogenic in Patients With Osteosarcoma Are De Novo: A Report From the Children's Oncology Group.

L. Mirabello, D. Malkin, N. Pankratz, 2020, JCO precision oncology.

Predicted leukocyte telomere length and risk of germ cell tumours

A. L. Frazier, N. Pankratz, A. J. Hooten, 2022, British Journal of Cancer.